Health technology
A couple or a transcart -rear week completes their acquisition or praise of $ 630 million. But CEO Glen Tullman calls him a fusion for a reason because recognition brings people, products and customers that Transcarent did not have. Glen deeply got into the new Transcarent product in terms of his navigation fed by AI, primary care, weight control, cancer service and associations. Where do you go in terms with employers (yes!), Medicare (not yet) and the aggressive expansion of services? And what can employers and their employees expect in terms of improving customer service for the medical care system? Glen and his team have a great vision, a great support of capital, and is definitely intended to move the needle about access to care, quality and cost.Matthew Holt
]